Related Experiment Videos
[Subhepatic abscess after cholecystectomy with coagulation active substance]
Abstract:
4 cases of postoperative subhepatic abscess formation after cholecystectomy are reported, where absorbable hemostatic agents for control of bleeding had been used. The etiology of these complications is discussed. The use of local hemostyptica is strongly disadvised in all possibly bacteriologically contaminated procedures.
Insights
Absorbable hemostatic agents used during cholecystectomy can lead to subhepatic abscesses. Surgeons should avoid these agents in procedures with potential bacterial contamination to prevent complications.
Area of Science:
- Surgical complications
- Gastrointestinal surgery
- Medical device safety
Context:
- Cholecystectomy (gallbladder removal) is a common surgical procedure.
- Postoperative subhepatic abscesses are a known, though infrequent, complication.
- The use of absorbable hemostatic agents is standard practice for bleeding control in many surgeries.
Purpose:
- To report cases of subhepatic abscess formation following cholecystectomy where absorbable hemostatic agents were used.
- To discuss the potential etiology linking these agents to abscess development.
- To advise against the use of local hemostyptics in potentially contaminated surgical fields.
Summary:
- Four cases of subhepatic abscesses after cholecystectomy are presented.
- Absorbable hemostatic agents were utilized for bleeding control in these instances.
- The findings suggest a possible link between these agents and abscess formation in contaminated surgical sites.
Impact:
- Highlights a potential risk associated with absorbable hemostatic agents in cholecystectomy.
- Informs surgical practice regarding the judicious use of hemostatic agents in potentially contaminated procedures.
- Emphasizes the need for careful consideration of materials used in surgery to minimize infection risk.